Last reviewed · How we verify
NCT02338024: MARTAS
Enhancing Linkage to HIV Care for Newly Detected HIV-positive Persons in Ukraine
NA trial testing Modified Antiretroviral Treatment Access Study intervention in HIV in 276 participants. Completed in 3 October 2017.
3 October 2017
Quick facts
| Lead sponsor | Ukrainian Institute on Public Health Policy |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 276 |
| Start date | 22 October 2015 |
| Primary completion | 3 October 2017 |
| Estimated completion | 3 October 2017 |
| Sites | 10 locations across Ukraine |
Drugs / interventions tested
- Modified Antiretroviral Treatment Access Study intervention
Conditions studied
- HIV — all drugs for HIV →
Sponsor
Ukrainian Institute on Public Health Policy
Who can join
18 and older, any sex, with HIV. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study proposes to assess whether a modified Antiretroviral Treatment Access Study intervention, proved to be effective in the U.S. and based on the nurse case management approach, can impact the enrollment in HIV care of recently detected HIV-positive patients in specialized health care clinics in three regions in Ukraine, using the existing local infrastructure. The proposed study addresses a significant public health issue of non-/late enrollment of HIV-positive persons in HIV care and treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Modified Antiretroviral Treatment Access Study (MARTAS): A Randomized Controlled Trial of the Efficacy of a Linkage-to-Care Intervention Among HIV-Positive Patients in Ukraine.
Neduzhko O, Postnov O, Sereda Y, Kulchynska R, et al · · 2020 · cited 6× · PMID 32333208 · DOI 10.1007/s10461-020-02873-7
Verify or expand the search:
- PubMed search for NCT02338024
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for HIV
Currently open trials in the same condition.
- NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
- NCT07221214 — GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV · Phase 2 · recruiting
- NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
- NCT07390474 — Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA i · Phase 1 · recruiting
- NCT07390955 — A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1 · Phase 1 · recruiting
Other Ukrainian Institute on Public Health Policy trials
Trials by the same sponsor.
- NCT05646212 — Integrating Treatment for Mental Disorders in Methadone Clinics in Ukraine · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02338024 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ukrainian Institute on Public Health Policy
- Last refreshed: 29 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02338024.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing